McNamara Peter

Chief Scientific Officer

McNamara Peter has filed 8 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Aug 26, 2026.

On the most recent filing, McNamara Peter is listed as Chief Scientific Officer at Tectonic Therapeutic, Inc. Inside the rolling window, McNamara Peter reported no open-market purchases and 6 open-market sales totaling $276K in TECX. The largest disclosed transaction in the window is a sale of 6,262 TECX shares on Mar 6, 2026, worth $189K.

Companies traded

Other insiders at TECX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$276K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
TECXSale$2KAug 26SEC ↗
TECXSale$2KAug 14SEC ↗
TECXSale$6KJul 1SEC ↗
TECXSale$189KMar 9SEC ↗
TECXSale$36KMar 5SEC ↗
TECXSale$41KMar 5SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has McNamara Peter made?

McNamara Peter has filed 8 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.

Which companies does McNamara Peter trade?

McNamara Peter has filed SEC Form 4 disclosures for 1 company, including TECX.

When was McNamara Peter's most recent SEC Form 4 filing?

McNamara Peter's most recent SEC Form 4 filing on Tracefour is dated Aug 26, 2026.

What is McNamara Peter's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, McNamara Peter is listed as Chief Scientific Officer.

What is McNamara Peter's total buy and sell value in the current window?

Inside the rolling retention window, McNamara Peter bought $0 and sold $276K based on SEC Form 4 filings.

What was McNamara Peter's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 6,262 TECX shares on 2026-03-06, worth $189K, per SEC Form 4 filings.